Second “Don't Eat Me” Signal Identified in Cancer Cells, Points to New Immunotherapies | The Stem Cellar
CD47: role in the immune system and application to cancer therapy | Cellular Oncology
CD47/SIRP alpha biochemical HTRF binding assay | Cisbio
Frontiers | Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis
CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and diabetes | American Journal of Physiology-Cell Physiology
CD47/SIRP alpha biochemical HTRF binding assay | Cisbio
063CE: Anti-CD47 Testing Interference with Connie Westhoff -
Cells | Free Full-Text | Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma
Leukocyte Surface Antigen CD47 - ACROBiosystems
Human lung adenocarcinoma CD47 is upregulated by interferon-γ and promotes tumor metastasis: Molecular Therapy - Oncolytics
SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy: Trends in Immunology
CD47/SIRPα pathway mediates cancer immune escape and immunotherapy
CD47 | Majeti Lab | Stanford Medicine
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells | Nature Communications
Frontiers | Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
Frontiers | Targeting CD47 as a Novel Immunotherapy for Breast Cancer
CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part Two) – Creative Biolabs Blog
Targeting CD47 for cancer immunotherapy | Journal of Hematology & Oncology | Full Text
CD47: role in the immune system and application to cancer therapy | Cellular Oncology
Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma | Haematologica
CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part Two) – Creative Biolabs Blog
The Antitumor Activities of Anti-CD47 Antibodies Require Fc-FcγR interactions | bioRxiv
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma: Cell
Localized CD47 blockade enhances immunotherapy for murine melanoma | PNAS
Regulation of CD47 expression in cancer cells - ScienceDirect
A) CD47-SIRPɑ interaction blocks macrophage phagocytosis of cancer... | Download Scientific Diagram
